Drug Information

General Information
Drug ID
DR01375
Drug Name
Neostigmine
Synonyms
Eustigmin; Eustigmine; Intrastigmina; Juvastigmin; Neostigmin; Neostigminum; Prostigmin; Prostigmine; Prozerin; Sulfonatooxymethane; Synstigmin; Syntostigmine; Vagostigmin; Vagostigmine; Neostigmine [BAN]; Neostigmine omega; M-Trimethylammoniumphenyldimethylcarbamate; Neostigmine (BAN); Prostigmin (TN); Vagostigmin (TN); [3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium; [3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium; [3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium bromide; Ammonium, (m-hydroxyphenyl)trimethyl-, dimethylcarbamate (ester); Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-(9CI); (m-Hydroxyphenyl)trimethylammonium dimethylcarbamate; (m-Hydroxyphenyl)trimethylammonium dimethylcarbamate (ester); 3-Trimethylammoniumphenyl N,N-dimethylcarbamate; 3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium; 3-{[(dimethylamino)carbonyl]oxy}-N,N,N-trimethylanilinium
Drug Type
Small molecular drug
Indication Myasthenia gravis [ICD11: 8C60] Approved [1]
Therapeutic Class
Parasympathomimetics
Structure
3D MOL 2D MOL
Formula
C12H19N2O2+
Canonical SMILES
CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C
InChI
InChI=1S/C12H19N2O2/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5/h6-9H,1-5H3/q+1
InChIKey
ALWKGYPQUAPLQC-UHFFFAOYSA-N
CAS Number
CAS 59-99-4
Pharmaceutical Properties Molecular Weight 223.29 Topological Polar Surface Area 29.5
Heavy Atom Count 16 Rotatable Bond Count 3
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 2
XLogP
1.5
PubChem CID
4456
PubChem SID
9467 , 866380 , 4398035 , 4635954 , 7980106 , 8152746 , 11111527 , 11111528 , 11335340 , 11335373 , 11360579 , 11360612 , 11363955 , 11366517 , 11369079 , 11373762 , 11377241 , 11461551 , 11461584 , 11466496 , 11467616 , 11485012 , 11486251 , 11489094 , 11491887 , 11494875 , 15121488 , 26756597 , 29223551 , 46509161 , 47216650 , 47291007 , 47365046 , 47588860 , 47736334 , 47736335 , 47810618 , 48110324 , 48416319 , 49698982 , 49868416 , 50100289 , 50100290 , 50103950 , 50765645 , 53786926 , 57322279 , 81044623 , 85787484 , 87691541
ChEBI ID
CHEBI:7514
TTD Drug ID
D08USJ
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Neostigmine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Improving the prediction of the brain disposition for orally administered drugs using BDDCS. Adv Drug Deliv Rev. 2012 Jan;64(1):95-109.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.